Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for thrombocytopenia in preeclampsia
2006-004881-15Phase 3Completed
- Sponsor
- CHU de Poitiers
- Start
- Jul 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Thrombocytopenia and preeclampsia comparing Methylprednisolone with Placebo (2 arms). Primary endpoint: Platelet count > 50 x 10^9/L at 36 hours. Started Jul 2007; status: completed.
02
Drugs
methylprednisolone
03
Conditions
Thrombocytopeniapreeclampsia
Beyond the preview
Go deeper on 2006-004881-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004881-15.